Moderate riskFDA DrugClass II

Mallinckrodt Acthar Gel injection recalled for glass and stopper particulate contamination

Mallinckrodt has recalled specific lots of Acthar Gel (repository corticotropin injection) due to the presence of glass and stopper pieces in the vials. This contamination could pose a risk if the affected medication is used. The recall affects 12,367 vials with lot numbers 1564-107 and 1564-107H, both expiring January 31, 2027.

From the FDA notice · Read the official notice ↗

What to do

  1. Check your Acthar Gel vials for lot numbers 1564-107 or 1564-107H with expiration date 1/31/2027.
  2. Do not use vials from these lots.
  3. Contact your pharmacy or healthcare provider for a replacement or alternative medication.
  4. Report any use of contaminated vials to the FDA MedWatch program or your healthcare provider.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2
Sold in
Nationwide
Made for
All ages (0 months and older)

Details

Units affected
12367 vials
Illnesses reported
None reported
Manufactured in
440 Us Highway 22 Ste 302, N/A, Bridgewater, NJ, United States
Classification
Class II
Recall number
D-0803-2026

In the FDA's words

Description
Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial, Rx Only, Mfd. for: Mallinckrodt ARD LLC, Bridgewater, NJ 08807, NDC 63004-8710-1 & NDC 63004-8710-2 Presence of particulate matter: glass and stopper piece Lot#: NDC 63004-8710-1 - 1564-107, exp 1/31/2027 NDC 63004-8710-2 - 1564-107H, exp 1/31/2027 Distribution: USA Nationwide Affected quantity: 12367 vials
Hazard
Presence of particulate matter: glass and stopper piece

Related topics

GlassParticulateDrugsSold nationwideMore from FDA Drug